Seattle biotech firm on verge of a groundbreaking cancer vaccine
Seattle Times
A decision is due this week on Dendreon’s application to bring the country’s first cancer-treatment vaccine to market. Dendreon’s prostate-cancer treatment, called Provenge, mobilizes patients’ own immune systems against their tumors.

Seattle Design Commission seeks ideas for empty or partially developed sites
City of Seattle
The Seattle Design Commission is seeking ideas for Holding Patterns, a program that finds interim uses for stalled project sites. They are seeking concepts to transform the following types of stalled sites: holes in the ground, surface lots, and ongoing construction above or below street level.

Microfabrication laboratory program aids small Wash. companies  
Washington Technology Center
Washington’s Microfabrication Laboratory Access Program provides eligible small companies with short-term, no-cost access to sophisticated and expensive microfabrication equipment critical to advancing specific research and development.

___________________________________________________________

As a service to the Seattle business community, the Office of Economic Development curates a daily business news blast, Daily Digest. As a new trial feature on Bottom Line, we’re posting a handful of stories from the Daily Digest every day.  Find the stories informative or helpful? Keep checking Bottom Line or sign up for Daily Digest to receive the full version in your inbox every day. Subscribe to the Daily Digest here.